The upregulation of both p53 and p21 in SCC cells following PRF treatment suggests an active effect of PRF on the p53/p21 signaling pathway, potentially enhancing the tumor suppressive function of these genes, inducing apoptosis, and promoting cell cycle arrest. The gene discussed is TP53; the disease is neoplasm.